Company Profiles

driven by the PitchBook Platform

Principia Biopharma

Description

Developer of cancer drugs designed to offer clinical and preclinical stage molecules for autoimmune, inflammatory diseases and oncology. The company's cancer drugs are developed by combine the dosing convenience of an oral small molecule drug with the specificity of an antibody, enabling patients to get new medicine with long lasting efficacy.

2008

Founded

PRIVATE

Status

11-50

Employees

Series B3

Latest Deal Type

$15.3M

Latest Deal Amount

$102M

Total Amount Raised

Description

Developer of cancer drugs designed to offer clinical and preclinical stage molecules for autoimmune, inflammatory diseases and oncology. The company's cancer drugs are developed by combine the dosing convenience of an oral small molecule drug with the specificity of an antibody, enabling patients to get new medicine with long lasting efficacy.

Website:

www.principiabio.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

400 East Jamie Court Suite 302 South San Francisco, CA 94080United States +1 (650) 416-7700
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Principia Biopharma's full profile, request a free trial.

Principia Biopharma Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Principia Biopharma Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Principia Biopharma Investors (6)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Mission Bay CapitalVenture CapitalMinority000 0000000 0000
MorgenthalerVenture CapitalMinority000 0000000 0000
New Leaf Venture PartnersVenture CapitalMinority000 0000000 0000
OrbiMedVenture CapitalMinority000 0000000 0000
Sofinnova VenturesVenture CapitalMinority000 0000000 0000
Mission Bay Capital Venture Capital
Morgenthaler Venture Capital
New Leaf Venture Partners Venture Capital
OrbiMed Venture Capital
Sofinnova Ventures Venture Capital

Principia Biopharma Executive Team (8)

NameTitleBoard
Seat
Contact
Info
Martin BablerChief Executive Officer, President & Board Member
Christopher ChaiChief Financial Officer
David Goldstein Ph.DChief Scientific Officer
Roy Hardiman JDChief Business Officer
Betsy SantosHead, Human Resources
Martin Babler Chief Executive Officer, President & Board Member
Christopher Chai Chief Financial Officer
David Goldstein Ph.D Chief Scientific Officer
Roy Hardiman JD Chief Business Officer
Betsy Santos Head, Human Resources

Principia Biopharma Board Members (11)

NameRepresentingRoleSinceContact
Info
Dan Becker Ph.DNew Leaf Venture PartnersPrincipal000 0000
David Kabakoff Ph.DSelfBoard Member000 0000
Jack Taunton Ph.DSelfBoard Observer000 0000
Lewis ShusterSelfDirector000 0000
Martin BablerPrincipia BiopharmaChief Executive Officer, President & Board Member000 0000
Dan Becker Ph.D Principal New Leaf Venture Partners
David Kabakoff Ph.D Board Member Self
Jack Taunton Ph.D Board Observer Self
Lewis Shuster Director Self
Martin Babler Chief Executive Officer, President & Board Member Principia Biopharma
Request full access to PitchBook